| 英文名称 |
中文名称 |
CAS号 |
操作 |
| PSB-SB-487 |
化合物PSB-SB-487 |
1399049-81-0 |
详细
|
| RBC10 |
RBC10 |
362503-73-9 |
详细
|
| ML-211 |
化合物ML-211 |
2205032-89-7 |
详细
|
| SGC707 |
N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1687736-54-4 |
详细
|
| PD089828 |
PD089828 |
179343-17-0 |
详细
|
| GSK J1 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1373422-53-7 |
详细
|
| Mycro3 |
944547-46-0 |
944547-46-0 |
详细
|
| GSK5182 |
CS-2620 |
877387-37-6 |
详细
|
| CRANAD-28 |
CRANAD 28 |
1623747-97-6 |
详细
|
| BPU-11 |
BPU-11 |
909664-41-1 |
详细
|
| ARN272 |
ARN272 |
488793-85-7 |
详细
|
| GSK484 hydrochloride |
CS-2265 |
1652591-81-5 |
详细
|
| CE3F4 |
143703-25-7 |
143703-25-7 |
详细
|
| RRX-001 |
RRX-001 |
925206-65-1 |
详细
|
| PCO371 |
PCO371 |
1613373-33-3 |
详细
|
| (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile |
GS-441524 |
1191237-69-0 |
详细
|
| MRTX1133 |
MRTX1133 |
2621928-55-8 |
详细
|
| NIBR-0213 |
NIBR 0213 |
1233332-14-3 |
详细
|
| KRAS G12D inhibitor 14 |
化合物 KRAS G12D INHIBITOR 14 |
2765254-39-3 |
详细
|
| BMS-191011 |
3-(5-CHLORO-2-HYDROXYBENZYL)-5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2(3H)-ONE |
202821-81-6 |
详细
|
| Galloflavin |
培黄素 |
568-80-9 |
详细
|
| ML261 |
2-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxamide |
902523-58-4 |
详细
|
| ISRIB |
ISRIB |
548470-11-7 |
详细
|
| BC-1215 |
化合物BC-1215 |
1507370-20-8 |
详细
|
| BC-1258 |
N,N′-Bis-(4-thiazol-2-yl-benzyl)-ethane-1,2-diamine |
1507370-40-2 |
详细
|
| K02288 |
K02288 |
1431985-92-0 |
详细
|
| CYM50308 |
CYM50308 |
1345858-76-5 |
详细
|
| FPH2(BRD-9424) |
FPH2 |
957485-64-2 |
详细
|
| Dafadine-A |
CS-1223 |
1065506-69-5 |
详细
|
| A 286982 |
A 286982 |
280749-17-9 |
详细
|
| ML-180 |
ML-180 |
863588-32-3 |
详细
|
| ML179 |
ML-179 |
1883548-87-5 |
详细
|
| PF 9601N |
PF 9601N |
133845-63-3 |
详细
|
| LDN-192960 dihydrochloride |
3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 |
184582-62-5 |
详细
|
| WS3 |
重复 |
1421227-52-2 |
详细
|
| PCNA-I 1 |
PCNA-I1 |
444930-42-1 |
详细
|
| WIKI4 |
化合物WIKI4 |
838818-26-1 |
详细
|
| Fluxapyroxad |
氟苯吡菌胺 |
907204-31-3 |
详细
|
| JW 55 |
JW-55 |
664993-53-7 |
详细
|
| ML277 |
ML-277 |
1401242-74-7 |
详细
|
| CRANAD-2 |
(T-4)-[(1E,6E)-1,7-bis[4-(Dimethylamino)phenyl]-1,6-heptadiene-3,5-dionato-O3,O5]difluoroboron |
1193447-34-5 |
详细
|
| CRT0066101 |
10MG |
956121-30-5 |
详细
|
| ML335 |
ML335 |
1069498-96-9 |
详细
|
| AA92593 |
4-Methoxy-3-methylphenyl piperidin-1-yl sulphone, 2-Methyl-4-[(piperidin-1-yl)sulphonyl]anisole |
457961-34-1 |
详细
|
| YMU1 |
Ethyl 4-(2-(4,6-dimethyl-3-oxoisothiazolo[5,4-b]pyridin-2(3H)-yl)acetyl)piperazine-1-carboxylate |
902589-96-2 |
详细
|
| ML 254 |
ML 254 |
1428630-86-7 |
详细
|
| PFK-015 |
PFK-015 |
4382-63-2 |
详细
|
| AT-56 |
AT-56 |
162640-98-4 |
详细
|
| PU-H54 |
化合物PU-H54 |
1454619-13-6 |
详细
|
| Kobe-0065 |
N-(3-CHLORO-4-METHYLPHENYL)-2-(2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL)HYDRAZINECARBOTHIOAMIDE |
436133-68-5 |
详细
|
| Nisoxetine hydrochloride |
盐酸尼索西汀 |
57754-86-6 |
详细
|
| ML303 |
ML303 |
1638211-04-7 |
详细
|
| CRT5 |
CRT5 |
1034297-58-9 |
详细
|
| HA-155 |
HA-155 |
1229652-22-5 |
详细
|
| Boronic acid, B-[4-[[4-[(Z)-[3-[(4-fluorophenyl)Methyl]-2,4-dioxo-5-thiazolidinylidene]Methyl]phenoxy]Methyl]phenyl]- |
CS-963 |
1312201-00-5 |
详细
|
| ASN03576800 |
ASN03576800 |
957513-35-8 |
详细
|
| NSC-703786 |
4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 |
260443-89-8 |
详细
|
| OS-3-106 |
N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-4-(thiazol-4-yl)benzamide |
1580000-17-4 |
详细
|
| Mps1-IN-3 |
1609584-72-6 |
1609584-72-6 |
详细
|
| Leukadherin-1 |
4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 |
344897-95-6 |
详细
|
| BMS453 |
BMS453 |
166977-43-1 |
详细
|
| VK-II-86 |
|
955371-84-3 |
详细
|
| Apcin |
Apcin |
300815-04-7 |
详细
|
| ML298 |
ML298 |
1426916-02-0 |
详细
|
| TH588 |
TH588 HYDROCHLORIDE |
1609960-31-7 |
详细
|
| Atglistatin |
ATGLISTATIN |
1469924-27-3 |
详细
|
| TM5007 |
化合物TM5007 |
342595-05-5 |
详细
|
| YM26734 |
YM 26734 |
144337-18-8 |
详细
|
| CYM 2503 |
(9H-芴-9 - 基)甲基((S)-1(((S)-6 - (叔丁氧基羰基)氨基-1 - ((4 - 甲基-2 - 氧代-1,2 - 二氢喹啉-7 - 基)氨基)-1 - 氧代己-2 - 基)氨基)-3 - 环己基-1 - 氧代丙-2 - 基)氨基甲酸叔丁酯 |
1308833-36-4 |
详细
|
| Inauhzin |
INAUHZIN |
309271-94-1 |
详细
|
| ML191 |
ML-191 |
931695-79-3 |
详细
|
| ML336 |
(E)-2-((1,4-二甲基哌嗪-2-亚基)氨基)-5-硝基-N-苯基苯甲酰胺 |
1613465-33-0 |
详细
|
| Carbamic acid |
((S)-5-((2R,3S)-3-(N-羟基甲酰胺基)-2-异丁基六氨基)-2-氧代-6-(噻唑-2-基氨基)己基)氨基甲酸苄酯 |
866924-39-2 |
详细
|
| GSK 2830371 |
GSK 2830371 |
1404456-53-6 |
详细
|
| TAE-1 |
2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide |
1414469-59-2 |
详细
|
| MONNA |
2-(4-甲氧基萘-2-基氨基)-5-硝基苯甲酸 |
1572936-83-4 |
详细
|
| 4BP-TQS |
4BP-TQS |
360791-49-7 |
详细
|
| 4'-Bromo-resveratrol |
5-[(E)-2-(4-溴苯基)乙烯基]间苯二酚 |
1224713-90-9 |
详细
|
| B355252 |
4-Chloro-N-(naphthalen-1-ylmethyl)-5-(3-(piperazin-1-yl)phenoxy)thiophene-2-sulfonamide |
1261576-81-1 |
详细
|
| CH5183284(Debio-1347) |
DEBIO-1347 |
1265229-25-1 |
详细
|
| ML162 |
ML162 |
1035072-16-2 |
详细
|
| LDN-211904 Oxalate |
N-(2-氯苯基)-6-(4-哌啶基)-咪唑并[1,2-A]吡啶-3-甲酰胺草酸盐 |
1198408-78-4 |
详细
|
| CGS-15943 |
CGS 15943 |
104615-18-1 |
详细
|
| JTE-013 |
JTE-013 |
383150-41-2 |
详细
|
| Imidazenil |
米达西尼 |
151271-08-8 |
详细
|
| FIT-039 |
FIT-039 |
1113044-49-7 |
详细
|
| VUF11418 |
N-[[(1R,5S)-6,6-二甲基双环[3.1.1]庚-2-烯-2-基]甲基]-2′-碘-N,N-二甲基[1,1′-联苯]-4-甲基碘化铵 |
1414376-85-4 |
详细
|
| GSK-843 |
GSK-843 |
1601496-05-2 |
详细
|
| NSC 177223 |
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide |
36707-00-3 |
详细
|
| SW155246 |
4-Chloro-N-(4-hydroxy-1-naphthalenyl)-3-nitro-benzenesulfonamide |
420092-79-1 |
详细
|
| ML-299 |
ML-299 |
1426916-00-8 |
详细
|
| HS-1793 |
化合物HS-1793 |
927885-00-5 |
详细
|
| ML240 |
ML240 |
1346527-98-7 |
详细
|
| VK-II-36 |
化合物VK-II-43 |
955371-66-1 |
详细
|
| Oseltamivir |
奥司他韦 |
196618-13-0 |
详细
|
| RO2959 hydrochloride |
化合物RO2959 HYDROCHLORIDE |
1219927-22-6 |
详细
|
| SR8278 |
SR8278;SR-8278;SR 8278 |
1254944-66-5 |
详细
|
| MCC950 |
MCC950 |
210826-40-7 |
详细
|
| VPC23019 |
VPC 23019 |
449173-19-7 |
详细
|
| GW779439X |
化合物GW779439X |
551919-98-3 |
详细
|